In this episode, we dive into the most commonly used viral vector in gene therapy—Adeno-Associated Virus (AAV). We're breaking down a recent Nature review article published in Signal Transduction and Targeted Therapy, which highlights the latest progress and persistent challenges in AAV-based gene therapies.
Tune in for a deep dive into the science and the road ahead for AAV in biotech.
Review Article: Adeno-Associated Virus as a Delivery Vector for Gene Therapy of Human Diseases (https://doi.org/10.1038/s41392-024-01780-w)